BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
6/16/21 Regeneron (REGN) REGEN-COV for COVID-19 Treatment Subscribers Only Subscribers Only Subscribers Only
6/16/21 Pfizer (PFE) Xeljanz/Xeljanz XR for COVID-19 Treatment Subscribers Only Subscribers Only Subscribers Only
6/16/21 Altimmune (ALT) ALT-801 for Non-Alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
6/16/21 Aprea (APRE) Eprenetapopt for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
6/15/21 Sage Therapeutics (SAGE) SAGE-217 for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
06/19/21 Subscribers Only Subscribers Only Trial Data - Other
Now - 06/20/21 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 06/20/21 Subscribers Only Subscribers Only Trial Announcement - Initiation
06/20/21 Subscribers Only Subscribers Only Trial Data - Other
Back to the top Back to the top